Tags

Type your tag names separated by a space and hit enter

Role of anandamide transporter in regulating calcitonin gene-related peptide production and blood pressure in hypertension.
J Hypertens. 2009 Jun; 27(6):1224-32.JH

Abstract

OBJECTIVES

To explore the role of anandamide (AEA) transporter in regulating calcitonin gene-related peptide (CGRP) production and blood pressure.

METHODS AND RESULTS

Plasma levels of AEA, CGRP, asymmetric dimethylarginine (ADMA) and nitric oxide in patients with essential hypertension, spontaneously hypertensive rats (SHRs) and 2 kidney 1 clip hypertensive rats and the CGRP mRNA expression in dorsal root ganglion of rats were measured. Peripheral blood lymphocytes were isolated to examine the AEA transporter activity, the role of AEA transporter in regulating CGRP mRNA expression or the effect of exogenous ADMA on AEA transporter activity. In both hypertensive patients and SHRs, the plasma level of AEA was elevated, but the AEA transporter activity was attenuated concomitantly with decreased CGRP production. Moreover, plasma ADMA level in SHRs was elevated accompanied by decreased nitric oxide level. By contrast, the plasma AEA level was elevated accompanied by increased CGRP production in 2 kidney 1 clip hypertensive rats, and there were no significant changes in plasma levels of ADMA, nitric oxide and the AEA transporter activity. In vitro, exogenous administration of AEA upregulated CGRP mRNA expression in lymphocytes, which was inhibited by AEA transporter blocker, AM404, and the AEA transporter activity was reduced by ADMA.

CONCLUSION

Decreased plasma CGRP level in patients with essential hypertension or SHRs is likely due to the reduced AEA transporter activity, and the increased ADMA level may account for the reduced AEA transporter activity.

Authors+Show Affiliations

Department of Pharmacology, School of Pharmaceutical Sciences, Central South University, Changsha, China.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

19462497

Citation

Li, Dai, et al. "Role of Anandamide Transporter in Regulating Calcitonin Gene-related Peptide Production and Blood Pressure in Hypertension." Journal of Hypertension, vol. 27, no. 6, 2009, pp. 1224-32.
Li D, Chen BM, Peng J, et al. Role of anandamide transporter in regulating calcitonin gene-related peptide production and blood pressure in hypertension. J Hypertens. 2009;27(6):1224-32.
Li, D., Chen, B. M., Peng, J., Zhang, Y. S., Li, X. H., Yuan, Q., Hu, C. P., Deng, H. W., & Li, Y. J. (2009). Role of anandamide transporter in regulating calcitonin gene-related peptide production and blood pressure in hypertension. Journal of Hypertension, 27(6), 1224-32.
Li D, et al. Role of Anandamide Transporter in Regulating Calcitonin Gene-related Peptide Production and Blood Pressure in Hypertension. J Hypertens. 2009;27(6):1224-32. PubMed PMID: 19462497.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Role of anandamide transporter in regulating calcitonin gene-related peptide production and blood pressure in hypertension. AU - Li,Dai, AU - Chen,Ben-Mei, AU - Peng,Jun, AU - Zhang,Yi-Shuai, AU - Li,Xiao-Hui, AU - Yuan,Qiong, AU - Hu,Chang-Ping, AU - Deng,Han-Wu, AU - Li,Yuan-Jian, PY - 2009/5/23/entrez PY - 2009/5/23/pubmed PY - 2009/8/26/medline SP - 1224 EP - 32 JF - Journal of hypertension JO - J Hypertens VL - 27 IS - 6 N2 - OBJECTIVES: To explore the role of anandamide (AEA) transporter in regulating calcitonin gene-related peptide (CGRP) production and blood pressure. METHODS AND RESULTS: Plasma levels of AEA, CGRP, asymmetric dimethylarginine (ADMA) and nitric oxide in patients with essential hypertension, spontaneously hypertensive rats (SHRs) and 2 kidney 1 clip hypertensive rats and the CGRP mRNA expression in dorsal root ganglion of rats were measured. Peripheral blood lymphocytes were isolated to examine the AEA transporter activity, the role of AEA transporter in regulating CGRP mRNA expression or the effect of exogenous ADMA on AEA transporter activity. In both hypertensive patients and SHRs, the plasma level of AEA was elevated, but the AEA transporter activity was attenuated concomitantly with decreased CGRP production. Moreover, plasma ADMA level in SHRs was elevated accompanied by decreased nitric oxide level. By contrast, the plasma AEA level was elevated accompanied by increased CGRP production in 2 kidney 1 clip hypertensive rats, and there were no significant changes in plasma levels of ADMA, nitric oxide and the AEA transporter activity. In vitro, exogenous administration of AEA upregulated CGRP mRNA expression in lymphocytes, which was inhibited by AEA transporter blocker, AM404, and the AEA transporter activity was reduced by ADMA. CONCLUSION: Decreased plasma CGRP level in patients with essential hypertension or SHRs is likely due to the reduced AEA transporter activity, and the increased ADMA level may account for the reduced AEA transporter activity. SN - 1473-5598 UR - https://www.unboundmedicine.com/medline/citation/19462497/Role_of_anandamide_transporter_in_regulating_calcitonin_gene_related_peptide_production_and_blood_pressure_in_hypertension_ L2 - https://doi.org/10.1097/hjh.0b013e328329bbd7 DB - PRIME DP - Unbound Medicine ER -